Hasil Pencarian - Katinger D

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates

    Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates oleh Moog C, Dereuddre-Bosquet N, Biedma M, Schmidt S, Decoville T, Mangeot I, Zolla-Pazner S, Vcelar B, Katinger D, Holl V, Le Grand R

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine

    P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine oleh Giemza E, Cai C, Cope A, Woodrow M, Wiggins R, Fraser C, Cole T, Jeffs S, Lacey CJ, Lewis DJ, Mahmhoud A, Katinger D, Cranage M, Shattock R

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

    Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans oleh Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: